These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 1660359)

  • 21. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
    Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
    Schmitz W; Eschenhagen T; Mende U; Müller FU; Neumann J; Scholz H
    Basic Res Cardiol; 1992; 87 Suppl 1():65-71. PubMed ID: 1323266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the phosphodiesterase inhibition by 2-(3-methoxy-5-methylsulfinyl-2-thienyl)-1H-imidazo-(4,5-c)-pyridine HCl and its sulfide- and sulfone derivatives in myocardial preparations from failing human hearts.
    Bethke T; Klimkiewicz A; Meyer W; Schumacher C; Schmitz W; Scholz H; Starbatty J; Wenzlaff H; Zimmermann W
    Arzneimittelforschung; 1995 Jul; 45(7):771-6. PubMed ID: 8573220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
    Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inotropic response to DPI 201-106 in the failing human heart.
    Böhm M; Diet F; Kemkes B; Wankerl M; Erdmann E
    Br J Pharmacol; 1989 Sep; 98(1):275-83. PubMed ID: 2553190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.
    Bethke T; Meyer W; Schmitz W; Scholz H; Stein B; Thomas K; Wenzlaff H
    Br J Pharmacol; 1992 Sep; 107(1):127-33. PubMed ID: 1384905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.
    Herzig JW; Chiesi M; Depersin H; Grüninger S; Hasenfuss G; Kubalek R; Leutert T; Pieske B; Pioch K; Wenk P; Holubarsch C
    Arzneimittelforschung; 1996 Jun; 46(6):586-93. PubMed ID: 8767348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
    Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
    J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium.
    Takahashi R; Endoh M
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):209-18. PubMed ID: 11210003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts.
    Bartel S; Stein B; Eschenhagen T; Mende U; Neumann J; Schmitz W; Krause EG; Karczewski P; Scholz H
    Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):171-9. PubMed ID: 8739244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of Ca2+ sensitizers--update 2001.
    Endoh M
    Cardiovasc Drugs Ther; 2001 Sep; 15(5):397-403. PubMed ID: 11855658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
    Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium.
    Takahashi R; Shimazaki Y; Endoh M
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1060-6. PubMed ID: 11504803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle.
    Lee JA; Ruegg JC; Allen DG
    Clin Sci (Lond); 1989 Jun; 76(6):609-18. PubMed ID: 2544344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of the inotropic effects of UD-CG 212 Cl, an active metabolite of pimobendan, on ferret papillary muscles.
    Komukai K; Kurihara S
    J Cardiovasc Pharmacol; 1996 May; 27(5):673-9. PubMed ID: 8859937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.